topotecan has been researched along with Kaposi Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Popanda, O; Staab, HJ; Thielmann, HW | 1 |
1 other study(ies) available for topotecan and Kaposi Disease
| Article | Year |
|---|---|
Subnuclear distribution of DNA topoisomerase I and Bax protein in normal and xeroderma pigmentosum fibroblasts after irradiation with UV light and gamma rays or treatment with topotecan.
Topics: Animals; Antigens, Neoplasm; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Cell Nucleus; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA-Binding Proteins; Enzyme Inhibitors; Fibroblasts; Gamma Rays; Humans; Immunohistochemistry; Isoenzymes; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Rabbits; Topotecan; Ultraviolet Rays; Xeroderma Pigmentosum | 1999 |